In pancreatic cancer, CCT8 was secreted from an invasive pancreatic cancer cell line, likely through the exosome pathway, and could serve as a liquid biopsy marker to monitor the progress of cancer patients (Liu P. et al., 2019). Here, CCT8 is linked to familial pancreatic carcinoma.